Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.790
+0.030 (1.70%)
Jun 4, 2026, 4:00 PM EDT - Market closed
Innate Pharma Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 28.09 | 66.4 | 70.61 | 84.23 | 103.76 |
Short-Term Investments | 6.22 | 14.37 | 21.85 | 17.26 | 16.08 |
Cash & Short-Term Investments | 34.31 | 80.77 | 92.46 | 101.49 | 119.84 |
Cash Growth | -57.52% | -12.64% | -8.90% | -15.31% | -20.97% |
Accounts Receivable | 12.4 | 4.97 | 55.56 | 38.35 | 18.42 |
Total Current Assets | 46.71 | 85.74 | 148.01 | 139.83 | 138.26 |
Net Property, Plant & Equipment | 4.36 | 5.13 | 6.32 | 8.54 | 10.17 |
Other Intangible Assets | - | - | 0.42 | 1.56 | 44.19 |
Long-Term Investments | 10.46 | 10.28 | 9.8 | 35.12 | 39.88 |
Other Long-Term Assets | 1.2 | 9.9 | 10.64 | 22.82 | 35 |
Total Assets | 62.72 | 111.06 | 175.19 | 207.86 | 267.5 |
Accounts Payable | 15.04 | 16.01 | 17.02 | 20.91 | 28.57 |
Current Portion of Leases | 8.8 | 8.71 | 8.94 | 2.1 | 30.75 |
Unearned Revenue | 9.33 | 8.06 | 13.51 | 16.78 | 19.92 |
Other Current Liabilities | 3.48 | 0.21 | 0.17 | 1.54 | 0.65 |
Total Current Liabilities | 36.65 | 32.98 | 39.64 | 41.34 | 79.89 |
Long-Term Leases | 13.77 | 22.29 | 30.96 | 40.15 | 13.5 |
Other Long-Term Liabilities | 34 | 46.96 | 52.69 | 72.23 | 66.67 |
Total Long-Term Liabilities | 47.77 | 69.24 | 83.65 | 112.37 | 80.17 |
Total Liabilities | 84.42 | 102.23 | 123.29 | 153.71 | 160.06 |
Common Stock | 4.69 | 4.19 | 4.04 | 4.01 | 3.98 |
Additional Paid-in Capital | 408.03 | 390.98 | 384.26 | 379.64 | 375.22 |
Accumulated Other Comprehensive Income | 1.12 | 0.03 | 0.5 | 0.82 | 0.46 |
Retained Earnings | -435.54 | -386.36 | -336.89 | -330.32 | -272.21 |
Shareholders' Equity | -21.7 | 8.83 | 51.9 | 54.15 | 107.44 |
Total Liabilities & Equity | 62.72 | 111.06 | 175.19 | 207.86 | 267.5 |
Total Debt | 22.57 | 31 | 39.89 | 42.25 | 44.25 |
Net Cash (Debt) | 11.74 | 49.78 | 52.56 | 59.23 | 75.59 |
Net Cash Growth | -76.42% | -5.30% | -11.26% | -21.63% | -42.98% |
Net Cash Per Share | 0.13 | 0.61 | 0.65 | 0.74 | 0.95 |
Book Value | -21.7 | 8.83 | 51.9 | 54.15 | 107.44 |
Book Value Per Share | -0.24 | 0.11 | 0.65 | 0.68 | 1.35 |
Tangible Book Value | -21.7 | 8.83 | 51.49 | 52.6 | 63.25 |
Tangible Book Value Per Share | -0.24 | 0.11 | 0.64 | 0.66 | 0.80 |